Molecular and biochemical analysis of protective protein/cathepsin A mutations: correlation with clinical severity in galactosialidosis [published erratum appears in Hum Mol Genet 1997 Jan;6(1):146]
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Mutations in the gene encoding lysosomal protective protein/cathepsin A (PPCA) are the cause of the lysosomal disorder galactosialidosis (GS). Depending on age of onset and severity of the symptoms, patients present with either an early infantile (EI), a late infantile (LI), or a juvenile/adult (J/A) form of the disease. To study genotype-phenotype correlation in this disorder, we have analyzed the mutations in the PPCA gene of eight clinically different patients. In two EI and one J/A patient, we have identified four novel point mutations (Val104Met, Leu208Pro, Gly411Ser and Ser23Tyr), that prevent phosphorylation and, hence, lysosomal localization and maturation of the mutant precursors. Two amino acid substitutions (Phe412Val and Tyr221Asn) are shared by five LI patients. These mutations appear to be pathognomonic for this phenotype, and determine the clinical outcome depending on whether they are present together or in combination with other mutations. The latter include a single base deletion and a novel amino acid change (Met378Thr), which generates an additional glycosylation site. Within the LI group, patients carrying the Phe412Val mutation are clinically more severe than those with the Tyr221Asn substitution. This is in agreement with the biochemical behavior of the Asn221-mutant protein, that is, like the Phe412Val protein, phosphorylated, routed to lysosomes and proteolytically processed, but its intralysosomal stability is intermediate between that of wild-type PPCA and Val412-PPCA. Overall, these results may explain the clinical heterogeneity observed in GS patients and may help to correlate mutant allelic combinations with specific clinical phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.
D'Azzo, A., Hoogeveen, A., Reuser, A. J., Robinson, D., & Galjaard, H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4535 · Cited by 365
Self-citationGaljart, N. J., Gillemans, N., Harris, A., van der Horst, G. T. J., Verheijen, F. W., Galjaard, H., & d'Azzo, A. (1988) · Cell · doi:10.1016/s0092-8674(88)90999-3 · Cited by 220
Self-citationGaljart, N. J., Morreau, H., Willemsen, R., Gillemans, N., Bonten, E. J., & d'Azzo, A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98751-x · Cited by 158
Self-citationThe relation between human lysosomal beta-galactosidase and its protective protein.
Hoogeveen, A. T., Verheijen, F. W., & Galjaard, H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44147-0 · Cited by 139
Rudenko, G., Bonten, E., d'Azzo, A., & GJ Hol, W. (1995) · Structure · doi:10.1016/s0969-2126(01)00260-x · Cited by 97
Self-citationIdentification and in Vitro Reconstitution of Lysosomal Neuraminidase from Human Placenta
van der Horst, G. T. J., Galjart, N. J., d'Azzo, A., Galjaard, H., & Verheijen, F. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85088-3 · Cited by 97
Self-citationVerheijen, F., Brossmer, R., & Galjaard, H. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)90911-1 · Cited by 95
Protective protein gene mutations in galactosialidosis.
Shimmoto, M., Fukuhara, Y., Itoh, K., Oshima, A., Sakuraba, H., & Suzuki, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116472 · Cited by 72 · cited 1×
“The second mutation is thought to have a greater effect on the catalytic rather than the protective function of the mutant protein (35).”
BackgroundLysosomal Protective Protein/Cathepsin A
Bonten, E. J., Galjart, N. J., Willemsen, R., Usmany, M., Vlak, J. M., & d'Azzo, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26441 · Cited by 59
Self-citation
Cited by
Neuraminidase 1 Is a Negative Regulator of Lysosomal Exocytosis
Yogalingam, G., Bonten, E. J., van de Vlekkert, D., Hu, H., Moshiach, S., Connell, S. A., & d'Azzo, A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.005 · Cited by 185
Self-citationvan der Spoel, A., Bonten, E., & d'Azzo, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1588 · Cited by 137
“, 1991), PPCA-Tyr221Asn, PPCA-Val104Met and PPCA-Leu208Pro (Zhou et al., 1996), subcloned into the mammalian expression vector pSC-TOP (Fornerod et al.”
BackgroundMethodSelf-citationBonten, E. J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2715 · Cited by 132
Galactosialidosis: review and analysis of CTSA gene mutations
Caciotti, A., Catarzi, S., Tonin, R., Lugli, L., Perez, C. R., Michelakakis, H., Mavridou, I., Donati, M. A., Guerrini, R., d’Azzo, A., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-114 · Cited by 73
“Mut Pred computational analysis PPCA three-dimensional reported outputs (Zhou et al. 1996 [22]; Rudenko et al. 1998 [19]; Takiguchi et al 2000 [23]) Philogenetic conservation Ref.”
MethodGain-of-glycosylation mutations
Vogt, G., Vogt, B., Chuzhanova, N., Julenius, K., Cooper, D. N., & Casanova, J.-L. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.04.008 · Cited by 67
Metadata
- Authors
- Zhou, X.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-12-01
- Volume
- 5
- Issue
- 12
- Pages
- 1977-1987
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2151707709
- Cited by
- 67
- References
- 13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular and biochemical analysis of protective protein/cathepsin A mutations: correlation with clinical severity in galactosialidosis [published erratum appears in Hum Mol Genet 1997 Jan;6(1):146]. https://app.cochat.ai/papers/10.1093/hmg/5.12.1977
- The paper
- Zhou, X. (1996). Molecular and biochemical analysis of protective protein/cathepsin A mutations: correlation with clinical severity in galactosialidosis [published erratum appears in Hum Mol Genet 1997 Jan;6(1):146]. Human Molecular Genetics. https://doi.org/10.1093/hmg/5.12.1977
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.